drugset / Trial / NCT01549470

Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda

NCT01549470

RandomizedParallel-groupTriple-blindPrevention

Summary

Currently, no vaccine prevents HIV infection. This study will test the safety and immune responses of an HIV-1 DNA vaccine in HIV-uninfected adults in a Ugandan population.

Timeline

Start
Primary completion
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject VRC-HIVDNA009-00-VP Vaccine 4 mg/ml Intramuscular